Global Anti-Viral Drugs Market Research Report 2020

Publisher Name :
Date: 24-Mar-2020
No. of pages: 97
Inquire Before Buying

The global Anti-Viral Drugs market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on Anti-Viral Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Viral Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Anti-Viral Drugs market is segmented into

- Nucleotide Polymerase Inhibitor

- Reverse Transcriptase Inhibitor

- Protease Inhibitor

Segment by Application

- HIV

- Hepatitis

- HSV

- Influenza

Global Anti-Viral Drugs Market: Regional Analysis

The Anti-Viral Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Anti-Viral Drugs market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Anti-Viral Drugs Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Anti-Viral Drugs market include:

- F. Hoffmann-La Roche

- GlaxoSmithKline

- Bristol-Myers-Squibb

- AbbVie

- Johnson & Johnson

- Merck & Co

- Aurobindo Pharma

- Cipla

- Dr Reddy's

Global Anti-Viral Drugs Market Research Report 2020

Table of Contents
1 Anti-Viral Drugs Market Overview
1.1 Product Overview and Scope of Anti-Viral Drugs
1.2 Anti-Viral Drugs Segment by Type
1.2.1 Global Anti-Viral Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Nucleotide Polymerase Inhibitor
1.2.3 Reverse Transcriptase Inhibitor
1.2.4 Protease Inhibitor
1.3 Anti-Viral Drugs Segment by Application
1.3.1 Anti-Viral Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Global Anti-Viral Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Viral Drugs Revenue 2015-2026
1.4.2 Global Anti-Viral Drugs Sales 2015-2026
1.4.3 Anti-Viral Drugs Market Size by Region: 2020 Versus 2026
2 Global Anti-Viral Drugs Market Competition by Manufacturers
2.1 Global Anti-Viral Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Viral Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Viral Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Viral Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Viral Drugs Market Competitive Situation and Trends
2.5.1 Anti-Viral Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Viral Drugs Players (Opinion Leaders)
3 Anti-Viral Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Viral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Viral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Viral Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Viral Drugs Sales by Country
3.3.2 North America Anti-Viral Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Viral Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Viral Drugs Sales by Country
3.4.2 Europe Anti-Viral Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Viral Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Viral Drugs Sales by Region
3.5.2 Asia Pacific Anti-Viral Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Viral Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Viral Drugs Sales by Country
3.6.2 Latin America Anti-Viral Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Viral Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Viral Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Viral Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Viral Drugs Historic Market Analysis by Type
4.1 Global Anti-Viral Drugs Sales Market Share by Type (2015-2020)
4.2 Global Anti-Viral Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Viral Drugs Price Market Share by Type (2015-2020)
4.4 Global Anti-Viral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Anti-Viral Drugs Historic Market Analysis by Application
5.1 Global Anti-Viral Drugs Sales Market Share by Application (2015-2020)
5.2 Global Anti-Viral Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Viral Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Anti-Viral Drugs Business
6.1 F. Hoffmann-La Roche
6.1.1 Corporation Information
6.1.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 F. Hoffmann-La Roche Products Offered
6.1.5 F. Hoffmann-La Roche Recent Development
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Anti-Viral Drugs Production Sites and Area Served
6.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GlaxoSmithKline Products Offered
6.2.5 GlaxoSmithKline Recent Development
6.3 Bristol-Myers-Squibb
6.3.1 Bristol-Myers-Squibb Anti-Viral Drugs Production Sites and Area Served
6.3.2 Bristol-Myers-Squibb Description, Business Overview and Total Revenue
6.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bristol-Myers-Squibb Products Offered
6.3.5 Bristol-Myers-Squibb Recent Development
6.4 AbbVie
6.4.1 AbbVie Anti-Viral Drugs Production Sites and Area Served
6.4.2 AbbVie Description, Business Overview and Total Revenue
6.4.3 AbbVie Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 AbbVie Products Offered
6.4.5 AbbVie Recent Development
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Anti-Viral Drugs Production Sites and Area Served
6.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Johnson & Johnson Products Offered
6.5.5 Johnson & Johnson Recent Development
6.6 Merck & Co
6.6.1 Merck & Co Anti-Viral Drugs Production Sites and Area Served
6.6.2 Merck & Co Description, Business Overview and Total Revenue
6.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Merck & Co Products Offered
6.6.5 Merck & Co Recent Development
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Anti-Viral Drugs Production Sites and Area Served
6.6.2 Aurobindo Pharma Description, Business Overview and Total Revenue
6.6.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aurobindo Pharma Products Offered
6.7.5 Aurobindo Pharma Recent Development
6.8 Cipla
6.8.1 Cipla Anti-Viral Drugs Production Sites and Area Served
6.8.2 Cipla Description, Business Overview and Total Revenue
6.8.3 Cipla Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Cipla Products Offered
6.8.5 Cipla Recent Development
6.9 Dr Reddy's
6.9.1 Dr Reddy's Anti-Viral Drugs Production Sites and Area Served
6.9.2 Dr Reddy's Description, Business Overview and Total Revenue
6.9.3 Dr Reddy's Anti-Viral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Dr Reddy's Products Offered
6.9.5 Dr Reddy's Recent Development
7 Anti-Viral Drugs Manufacturing Cost Analysis
7.1 Anti-Viral Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Viral Drugs
7.4 Anti-Viral Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Viral Drugs Distributors List
8.3 Anti-Viral Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Anti-Viral Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Viral Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Viral Drugs by Type (2021-2026)
10.2 Anti-Viral Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Viral Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Viral Drugs by Application (2021-2026)
10.3 Anti-Viral Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Viral Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Viral Drugs by Region (2021-2026)
10.4 North America Anti-Viral Drugs Estimates and Projections (2021-2026)
10.5 Europe Anti-Viral Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Viral Drugs Estimates and Projections (2021-2026)
10.7 Latin America Anti-Viral Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Viral Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Viral Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Viral Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Viral Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-Viral Drugs Manufacturers Covered in This Study
Table 5. Global Anti-Viral Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Anti-Viral Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-Viral Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-Viral Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-Viral Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-Viral Drugs Sales Sites and Area Served
Table 11. Manufacturers Anti-Viral Drugs Product Types
Table 12. Global Anti-Viral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Viral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Viral Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-Viral Drugs Players
Table 16. Global Anti-Viral Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Anti-Viral Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Anti-Viral Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-Viral Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-Viral Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Anti-Viral Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-Viral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-Viral Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-Viral Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Anti-Viral Drugs Sales Share by Type (2015-2020)
Table 42. Global Anti-Viral Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-Viral Drugs Revenue Share by Type (2015-2020)
Table 44. Global Anti-Viral Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Anti-Viral Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Anti-Viral Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Anti-Viral Drugs Sales Growth Rate by Application (2015-2020)
Table 48. F. Hoffmann-La Roche Anti-Viral Drugs Corporation Information
Table 49. F. Hoffmann-La Roche Description and Business Overview
Table 50. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. F. Hoffmann-La Roche Main Product
Table 52. F. Hoffmann-La Roche Recent Development
Table 53. GlaxoSmithKline Anti-Viral Drugs Corporation Information
Table 54. GlaxoSmithKline Corporation Information
Table 55. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. GlaxoSmithKline Main Product
Table 57. GlaxoSmithKline Recent Development
Table 58. Bristol-Myers-Squibb Anti-Viral Drugs Corporation Information
Table 59. Bristol-Myers-Squibb Corporation Information
Table 60. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Bristol-Myers-Squibb Main Product
Table 62. Bristol-Myers-Squibb Recent Development
Table 63. AbbVie Anti-Viral Drugs Corporation Information
Table 64. AbbVie Corporation Information
Table 65. AbbVie Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. AbbVie Main Product
Table 67. AbbVie Recent Development
Table 68. Johnson & Johnson Anti-Viral Drugs Corporation Information
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Johnson & Johnson Main Product
Table 72. Johnson & Johnson Recent Development
Table 73. Merck & Co Anti-Viral Drugs Corporation Information
Table 74. Merck & Co Corporation Information
Table 75. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Merck & Co Main Product
Table 77. Merck & Co Recent Development
Table 78. Aurobindo Pharma Anti-Viral Drugs Corporation Information
Table 79. Aurobindo Pharma Corporation Information
Table 80. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Aurobindo Pharma Main Product
Table 82. Aurobindo Pharma Recent Development
Table 83. Cipla Anti-Viral Drugs Corporation Information
Table 84. Cipla Corporation Information
Table 85. Cipla Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Cipla Main Product
Table 87. Cipla Recent Development
Table 88. Dr Reddy's Anti-Viral Drugs Corporation Information
Table 89. Dr Reddy's Corporation Information
Table 90. Dr Reddy's Anti-Viral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Dr Reddy's Main Product
Table 92. Dr Reddy's Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Anti-Viral Drugs Distributors List
Table 96. Anti-Viral Drugs Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Anti-Viral Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Anti-Viral Drugs Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Anti-Viral Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Anti-Viral Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Anti-Viral Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Anti-Viral Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Anti-Viral Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Anti-Viral Drugs Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Anti-Viral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Anti-Viral Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-Viral Drugs
Figure 2. Global Anti-Viral Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Nucleotide Polymerase Inhibitor Product Picture
Figure 4. Reverse Transcriptase Inhibitor Product Picture
Figure 5. Protease Inhibitor Product Picture
Figure 6. Global Anti-Viral Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 7. HIV
Figure 8. Hepatitis
Figure 9. HSV
Figure 10. Influenza
Figure 11. Global Anti-Viral Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Viral Drugs Sales Capacity (K Units) (2015-2026)
Figure 13. Global Anti-Viral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Anti-Viral Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Anti-Viral Drugs Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Anti-Viral Drugs Revenue in 2019
Figure 17. Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Anti-Viral Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Anti-Viral Drugs Sales Market Share by Region in 2019
Figure 20. Global Anti-Viral Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Anti-Viral Drugs Revenue Market Share by Region in 2019
Figure 22. North America Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 23. North America Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 24. U.S. Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 29. Europe Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 30. Germany Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Anti-Viral Drugs Sales Market Share by Region in 2019
Figure 41. Asia Pacific Anti-Viral Drugs Revenue Market Share by Region in 2019
Figure 42. China Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 65. Latin America Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 66. Mexico Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 74. Turkey Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Anti-Viral Drugs by Type (2015-2020)
Figure 81. Sales Market Share of Anti-Viral Drugs by Type in 2019
Figure 82. Revenue Share of Anti-Viral Drugs by Type (2015-2020)
Figure 83. Revenue Market Share of Anti-Viral Drugs by Type in 2019
Figure 84. Global Anti-Viral Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Anti-Viral Drugs Sales Market Share by Application (2015-2020)
Figure 86. Global Anti-Viral Drugs Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Anti-Viral Drugs by Application (2015-2020)
Figure 88. Global Revenue Share of Anti-Viral Drugs by Application in 2020
Figure 89. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Bristol-Myers-Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Dr Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Anti-Viral Drugs
Figure 100. Manufacturing Process Analysis of Anti-Viral Drugs
Figure 101. Anti-Viral Drugs Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Anti-Viral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Anti-Viral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Anti-Viral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Anti-Viral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Anti-Viral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Anti-Viral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Anti-Viral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Anti-Viral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Anti-Viral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Anti-Viral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
  • Global Beta-2 Microglobulin (B2M) Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Beta-2 Microglobulin (B2M) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Beta-2 Microglobulin (B2M) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Beta-2 Microglobuli......
  • Global Hydrofiber Dressings Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Hydrofiber Dressings market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hydrofiber Dressings business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Hydrofiber Dressings market by ......
  • Global Soft Gelatin Capsules (Softgels) Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 158
    According to this study, over the next five years the Soft Gelatin Capsules (Softgels) market will register a 5.6%% CAGR in terms of revenue, the global market size will reach $ 4656.3 million by 2025, from $ 3741.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Soft Gelatin Capsules (Softgels) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities o......
  • Global Mesalamine Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 164
    According to this study, over the next five years the Mesalamine market will register a 3.3%% CAGR in terms of revenue, the global market size will reach $ 152.3 million by 2025, from $ 133.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mesalamine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine market by product type, applicati......
  • Global mRNA Vaccines & Therapeutics Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the mRNA Vaccines & Therapeutics market will register a 34.7%% CAGR in terms of revenue, the global market size will reach $ 6166.3 million by 2025, from $ 1874.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in mRNA Vaccines & Therapeutics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of mRNA ......
  • Global Crude Heparin Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Crude Heparin market will register a 9.1%% CAGR in terms of revenue, the global market size will reach $ 3996.8 million by 2025, from $ 2819.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Crude Heparin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Crude Heparin market by product type......
  • Global Albumin (as Excipient) Market Growth 2020-2025
    Published: 21-Oct-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Albumin (as Excipient) market will register a 6.3%% CAGR in terms of revenue, the global market size will reach $ 5262.5 million by 2025, from $ 4120.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albumin (as Excipient) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipi......
  • Global Antiviral Agents Eye Drops Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 116
    The Antiviral Agents Eye Drops market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antiviral Agents Eye Drops market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antiviral Agents Eye Drops market. The report focuses on well-known providers in the global Antiviral Agents Eye Drops industry, marke......
  • Global Aquaculture Vaccine Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 114
    The Aquaculture Vaccine market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Aquaculture Vaccine market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Aquaculture Vaccine market. The report focuses on well-known providers in the global Aquaculture Vaccine industry, market segments, competition, and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs